CIDI (03881.HK) Sets 30 Mar 2026 Board Meeting to Approve FY2025 Results

Bulletin Express
03/13

CiDi Inc. (CIDI, stock code 03881.HK) announced that its board of directors will convene on 30 March 2026 to review and approve the Group’s audited financial results for the year ended 31 December 2025 and to authorize their publication.

The notice, dated 13 March 2026, states that additional routine matters may also be addressed during the session.

Board composition at the time of the announcement is as follows: • Executive Directors: Dr. Ma Wei and Dr. Albert S. Hu (also Chief Executive Officer) • Non-Executive Directors: Prof. Li Zexiang, Ms. Yang Xi and Dr. Li Zhiyong • Independent Non-Executive Directors: Dr. Li Xiaoyuan, Prof. Tan Guangrong and Mr. Zhang Jiangang

The company did not disclose any financial figures in this notice; those details are expected upon release of the FY2025 results after board approval.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10